Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 1
1976 2
1977 3
1978 3
1979 2
1980 2
1981 1
1982 4
1983 6
1984 3
1985 5
1986 2
1987 4
1988 2
1989 7
1990 2
1991 1
1992 2
1993 3
1994 1
1996 5
1997 2
1998 3
1999 2
2001 2
2019 2
2021 4
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Results by year
Filters applied: . Clear all
Page 1
Ribosome-tetracycline interactions.
Tritton TR. Tritton TR. Biochemistry. 1977 Sep 6;16(18):4133-8. doi: 10.1021/bi00637a029. Biochemistry. 1977. PMID: 334241 No abstract available.
Anthracycline resistance.
Bhushan A, Kermode JC, Posada J, Tritton TR. Bhushan A, et al. Among authors: tritton tr. Cancer Treat Res. 1989;48:55-72. doi: 10.1007/978-1-4613-1601-5_5. Cancer Treat Res. 1989. PMID: 2577141 Review. No abstract available.
Cell surface actions of adriamycin.
Tritton TR. Tritton TR. Pharmacol Ther. 1991;49(3):293-309. doi: 10.1016/0163-7258(91)90060-y. Pharmacol Ther. 1991. PMID: 2052627 Review.
Spin-labeled ribosomes.
Tritton TR. Tritton TR. Biochemistry. 1978 Sep 19;17(19):3959-64. doi: 10.1021/bi00612a013. Biochemistry. 1978. PMID: 213100 No abstract available.
Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.
Webb J, Mount J, von Arx LB, Rachman J, Spanopoulos D, Wood R, Tritton T, Massey O, Idris I. Webb J, et al. Among authors: tritton t. Diabetes Obes Metab. 2022 Feb;24(2):289-295. doi: 10.1111/dom.14580. Epub 2021 Nov 24. Diabetes Obes Metab. 2022. PMID: 34668637 Free PMC article.
Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England.
Czira A, Banks V, Requena G, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS. Czira A, et al. Among authors: tritton t. BMJ Open Respir Res. 2022 Sep;9(1):e001243. doi: 10.1136/bmjresp-2022-001243. BMJ Open Respir Res. 2022. PMID: 36171051 Free PMC article.
Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist Dual Therapy in a Primary Care Setting in England.
Requena G, Banks V, Czira A, Wood R, Tritton T, Wild R, Compton C, Duarte M, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2022 Aug 10;17:1781-1795. doi: 10.2147/COPD.S365480. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35983168 Free PMC article.
Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Halpin DMG, Rothnie KJ, Banks V, Czira A, Compton C, Wood R, Tritton T, Massey O, Wild R, Snowise N, Nikitin K, Sharma R, Ismaila AS, Vogelmeier CF. Halpin DMG, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2022 Sep 24;17:2417-2429. doi: 10.2147/COPD.S370540. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36185170 Free PMC article.
83 results